BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10926795)

  • 1. Intratumoral genetic heterogeneity and progression of endometrioid type endometrial adenocarcinomas.
    Faquin WC; Fitzgerald JT; Boynton KA; Mutter GL
    Gynecol Oncol; 2000 Aug; 78(2):152-7. PubMed ID: 10926795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
    An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
    Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors.
    Nishimura N; Hachisuga T; Nabeshima K; Kawarabayashi T
    Int J Oncol; 2005 Dec; 27(6):1519-26. PubMed ID: 16273207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.
    Cao SN; Chang KH; Luthra R; Liu J
    Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
    Stefansson IM; Salvesen HB; Immervoll H; Akslen LA
    Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer.
    Mutter GL; Boynton KA; Faquin WC; Ruiz RE; Jovanovic AS
    Cancer Res; 1996 Oct; 56(19):4483-6. PubMed ID: 8813144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity in lung and colorectal carcinoma as revealed by microsatellite analysis in plasma or tumor tissue DNA.
    Beau-Faller M; Weber JC; Schneider A; Guèrin E; Gasser B; Ducrocq X; Jaeck D; Wihlm JM; Quoix E; Gaub MP
    Cancer; 2003 May; 97(9):2308-17. PubMed ID: 12712488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
    Ali A; Black D; Soslow RA
    Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
    Chan QK; Khoo US; Ngan HY; Yang CQ; Xue WC; Chan KY; Chiu PM; Ip PP; Cheung AN
    Clin Cancer Res; 2005 Apr; 11(8):2981-5. PubMed ID: 15837751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
    Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
    Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
    Stokes GN; Shelton JB; Zahn CM; Kendall BS
    Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma.
    Garuti G; De Giorgi O; Sambruni I; Cellani F; Luerti M
    Gynecol Oncol; 2001 Jun; 81(3):408-13. PubMed ID: 11371130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF; Liu MQ; Zhao Q
    Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
    Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
    J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling.
    Risinger JI; Maxwell GL; Chandramouli GV; Aprelikova O; Litzi T; Umar A; Berchuck A; Barrett JC
    Cancer Res; 2005 Jun; 65(12):5031-7. PubMed ID: 15958545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.